Allschwil, Switzerland

Corinna Grisostomi

USPTO Granted Patents = 21 

 

 

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):Explore Patents

Title: Corinna Grisostomi: Innovator in Pharmaceutical Chemistry

Introduction

Corinna Grisostomi, based in Allschwil, Switzerland, is a prominent inventor in the field of pharmaceutical chemistry, holding an impressive total of 19 patents. Her contributions significantly advance the development of novel therapeutic agents, particularly in the area of Galectin-3 inhibitors.

Latest Patents

Among her latest inventions are the "Alpha-D-galactopyranoside derivatives", which involve compounds characterized by specific structural formulas and their preparation methods. These compounds not only include various functional groups but also demonstrate potent activity as pharmaceutical agents, particularly for inhibiting Galectin-3. Another noteworthy patent is for "Spiro derivatives of Alpha-D-galactopyranosides," which similarly focuses on the development of compounds that are crucial for pharmaceutical compositions designed to combat diseases associated with Galectin-3.

Career Highlights

Corinna has had a distinguished career, contributing her expertise to leading pharmaceutical companies, including Actelion Pharmaceuticals Ltd and Idorsia Pharmaceuticals Ltd. Her work has been pivotal in transforming scientific research into viable medical solutions, establishing her as a leading figure in the industry.

Collaborations

Throughout her career, Corinna has collaborated with notable professionals such as Daniel Bur and Olivier Corminboeuf. These partnerships have fostered a rich exchange of ideas and innovation, further enhancing her research outcomes and the overall impact of her work in pharmaceutical sciences.

Conclusion

Corinna Grisostomi exemplifies the spirit of innovation in modern pharmaceutical research. With her extensive patent portfolio and collaborations, she continues to contribute valuable advancements to the medical field, offering promising solutions for various health challenges. Her ongoing work inspires future generations of inventors and researchers striving to improve global health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…